P-270. Comparing Regression and Machine Learning Methods for Predicting Readmission Risk among People with HIV

Abstract Background Predictive models can help identify high-risk patients who may benefit from targeted interventions. We evaluated the utility of predictive models for classifying 30-day hospital readmission risk among participants in the UNC CFAR HIV Clinical Cohort during 2014-2024.Table 1Candidate predictors included in modelsTable 2Summary of model evaluation metrics and most influential predictors Methods We compared logistic regression (LR), elastic net (EN), random forest (RF) and extreme gradient boosting (XGBoost) models. Readmission was defined as an admission within 30 days after discharge. Models were trained on a 75% random sample of data with 25% held out for testing. All models except LR used 5-fold cross-validation for hyperparameter tuning. We included readily available clinical and demographic predictors (Table 1) and evaluated model performance using metrics including area under the receiver operator curve (AUC), sensitivity and specificity. The variables most influencing predictions were determined using model coefficients (LR, EN) or built-in feature importance (RF, XGBoost). In separate multivariable models we estimated adjusted risk ratios (aRRs) for the top predictors. Results Among 804 participants with an index hospitalization, 98 (12%) were readmitted. Predictive performance was limited, with AUCs ranging from 0.55 (LR) to 0.62 (EN) (Table 2). Length of stay > 3 days and history of an AIDS-defining illness (Hx-ADI) were among the top predictors across all models. Primary discharge diagnosis of HIV, nadir CD4 > 200 cells/µl and male gender were each included in only 1 of the 4 models. Length of stay > 3 days and Hx-ADI were each associated with significantly increased readmission risk in multivariable models: aRR 2.4 (95% CI 1.5-3.8) and 1.7 (95% CI 1.1-2.7), respectively. Conclusion Predicting 30-day readmission in this population remains challenging. Larger datasets and inclusion of additional predictors, including social and behavioral factors, may be necessary for improved performance. We identified length of stay > 3 days and Hx-ADI as important predictors, each associated with approximately doubled risk of readmission. Although lacking biological plausibility, nadir CD4 > 200 cells/µl was among the top predictors in the LR model. This shows that for a generalizable model, regularization tuned by cross-validation is necessary to minimize the impact of spurious associations. Disclosures Joseph J. Eron, MD, Gilead Sciences: Advisor/Consultant|Gilead Sciences: Grant/Research Support|Merck: Advisor/Consultant|Merck: Grant/Research Support|ViiV Healthcare: Advisor/Consultant|ViiV Healthcare: Grant/Research Support

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2026-01-01
DOI
https://doi.org/10.1093/ofid/ofaf695.491
Primary Topic
HIV-related health complications and treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

P-270. Comparing Regression and Machine Learning Methods for Predicting Readmission Risk among People with HIV

Amanda Moy, Lindsay Browne, Heather Henderson, Joseph J Eron et al.
Open Forum Infectious Diseases
HIV-related health complications and treatments
article

P-270. Comparing Regression and Machine Learning Methods for Predicting Readmission Risk among People with HIV

Amanda Moy, Lindsay Browne, Heather Henderson, Joseph J Eron, Alex Commanday, Sonia Napravnik
article en

Abstract

Abstract Background Predictive models can help identify high-risk patients who may benefit from targeted interventions. We evaluated the utility of predictive models for classifying 30-day hospital readmission risk among participants in the UNC CFAR HIV Clinical Cohort during 2014-2024.Table 1Candidate predictors included in modelsTable 2Summary of model evaluation metrics and most influential predictors Methods We compared logistic regression (LR), elastic net (EN), random forest (RF) and extreme gradient boosting (XGBoost) models. Readmission was defined as an admission within 30 days after discharge. Models were trained on a 75% random sample of data with 25% held out for testing. All models except LR used 5-fold cross-validation for hyperparameter tuning. We included readily available clinical and demographic predictors (Table 1) and evaluated model performance using metrics including area under the receiver operator curve (AUC), sensitivity and specificity. The variables most influencing predictions were determined using model coefficients (LR, EN) or built-in feature importance (RF, XGBoost). In separate multivariable models we estimated adjusted risk ratios (aRRs) for the top predictors. Results Among 804 participants with an index hospitalization, 98 (12%) were readmitted. Predictive performance was limited, with AUCs ranging from 0.55 (LR) to 0.62 (EN) (Table 2). Length of stay > 3 days and history of an AIDS-defining illness (Hx-ADI) were among the top predictors across all models. Primary discharge diagnosis of HIV, nadir CD4 > 200 cells/µl and male gender were each included in only 1 of the 4 models. Length of stay > 3 days and Hx-ADI were each associated with significantly increased readmission risk in multivariable models: aRR 2.4 (95% CI 1.5-3.8) and 1.7 (95% CI 1.1-2.7), respectively. Conclusion Predicting 30-day readmission in this population remains challenging. Larger datasets and inclusion of additional predictors, including social and behavioral factors, may be necessary for improved performance. We identified length of stay > 3 days and Hx-ADI as important predictors, each associated with approximately doubled risk of readmission. Although lacking biological plausibility, nadir CD4 > 200 cells/µl was among the top predictors in the LR model. This shows that for a generalizable model, regularization tuned by cross-validation is necessary to minimize the impact of spurious associations. Disclosures Joseph J. Eron, MD, Gilead Sciences: Advisor/Consultant|Gilead Sciences: Grant/Research Support|Merck: Advisor/Consultant|Merck: Grant/Research Support|ViiV Healthcare: Advisor/Consultant|ViiV Healthcare: Grant/Research Support

Open Forum Infectious DiseasesVol. 13(Supplement_1)
University of North Carolina at Chapel Hill (US), University of North Carolina Health Care (US)
Good health and well-being
Openalex Percentile: Top 92%
HIV-related health complications and treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.